Clinical Trials Logo

Thyroid Dysfunction clinical trials

View clinical trials related to Thyroid Dysfunction.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06293534 Not yet recruiting - Thyroid Dysfunction Clinical Trials

Thyroid Dysfunction in Patients With Major Psychiatric Disorders

Start date: March 1, 2024
Phase:
Study type: Observational [Patient Registry]

Thyroid dysfunction in major psychiatric disorders in psychiatric patients admitted to psychiatric unit of assiut university hospital

NCT ID: NCT06272721 Not yet recruiting - Pregnancy Related Clinical Trials

Hypothyroidism in Pregnancy and Neuropsychological Development in Children

OHPLDO
Start date: February 19, 2024
Phase: N/A
Study type: Interventional

Thyroid dysfunction, particularly hypothyroidism and thyroid autoimmunity, impacts a significant proportion of pregnant women, affecting 3% and 17% respectively. The management of thyroid-stimulating hormone (TSH) levels is crucial, with subclinical hypothyroidism often defined by a TSH upper reference limit of 4 mU/L, and overt hypothyroidism by TSH levels above 10 mU/L and potentially low free thyroxine (FT4) levels. Levothyroxine (LT4) treatment is strongly advised for TSH levels above 10 mU/L, with the timing of intervention being critical during the first trimester for optimal fetal brain development. Research shows that untreated maternal hypothyroidism can significantly impact the neuropsychological development of the child, affecting cognitive, verbal, and motor skills. Even subclinical maternal hypothyroidism has been associated with lower IQ and motor scores in children. Early pregnancy intervention is key, as treatment after the first trimester may not improve children's neurocognitive outcomes. Regarding sensory and linguistic development, evidence is mixed, but recent studies suggest that maternal hypothyroidism can lead to expressive language delays. The Development Quotient (DQ) is used to assess cognitive and motor development in children, with the Griffiths Mental Development Scales II being a common tool. This study aims to explore the effects of treated maternal hypothyroidism during pregnancy on children's neurodevelopment, focusing on learning and language. It includes 31 women diagnosed with hypothyroidism and a control group of 21 euthyroid women, along with their children. The study emphasizes the importance of early detection and treatment of maternal hypothyroidism for preventing adverse neurodevelopmental outcomes in offspring. Statistical analysis will be conducted using SPSS, with a focus on maternal-fetal outcomes and cognitive-neuropsychological outcomes, highlighting the significance of early intervention.

NCT ID: NCT06185309 Not yet recruiting - Depression Clinical Trials

Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction

Start date: January 1, 2024
Phase:
Study type: Observational [Patient Registry]

1. Evaluate psychiatric symptoms in patients with thyroid dysfunction. 2. Investigate effect of treatment on psychiatric symptoms after 2 months.

NCT ID: NCT04809454 Not yet recruiting - Thyroid Dysfunction Clinical Trials

Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt

I2 and thyroid
Start date: October 2021
Phase:
Study type: Observational

Thyroxin a vital hormone for life lot of body functions depend on proper functioning on pituitary thyroid axis. it exists in two major forms Thyroxine (T4) and (T3) , each of them containing two iodine atoms on their inner (tyrosine) ring. Synthesis of reasonable quantities of thyroid hormones requires adequate iodine intake to allow sufficient thyroidal uptake. The World Health Organization (WHO) recommendation for daily intake of iodine is 150 μg for children ≥12 years and adults, and 250 μg for pregnant and lactating women. However as we know optimum amount of iodine is required for normal pituitary thyroid axis like wise excessive intake may cause over functioning of axis hence over production of hormone that can be manifested both clinically and biochemically. This study is designed to observe the frequency of over hyperthyroidism in patients taking iodinated salt.

NCT ID: NCT04613323 Not yet recruiting - Pregnancy Related Clinical Trials

Management of Thyroid Function in Hashimoto's Thyroiditis During Pregnancy

Start date: January 1, 2022
Phase:
Study type: Observational

The management of thyroid function in pregnancy has been object of several guidelines in the last years. Normal thyroid function reduces prenatal and post-natal risks and gestational complaints. Trimester specific reference values of thyroid hormones and thyroid stimulating hormone (TSH) are available for selected geographic population but its are not yet are available in our country. Hashimoto's thyroiditis (HT) is the most frequent autoimmune thyroid disease which can induce thyroid dysfunction, mainly sub-clinical hypothyroidism. Due to the large incidence in women HT and its potential link with thyroid dysfunction this disease could be search and monitored before pregnancy. Anyway a strong recommendation is to test TSH levels in all patients seeking pregnancy at risk for thyroid dysfunction for a history or current symptoms/signs of thyroid dysfunction, known positivity od thyroid autoimmunity or goiter, a history of neck radiation, age >30 years, diabetes mellitus, previous infertility or pregnant loss, morbid obesity, living in area of moderate-severe iodine deficiency or recent administration of drugs/substance interfering with thyroid function.

NCT ID: NCT04323007 Not yet recruiting - Thyroid Dysfunction Clinical Trials

Thyroid Dysfunction in Patients With Nephrotic Syndrome

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

This study is to evaluate Thyroid Hormone profile in patients with Nephrotic syndrome to identify clinical predictor of Thyroid dysfunction in patients with Nephrotic syndrome

NCT ID: NCT03602534 Not yet recruiting - Acne Vulgaris Clinical Trials

Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ]

Start date: December 2018
Phase:
Study type: Observational

Acne is a chronic inflammatory disease of the pilo-sebaceous unit with a multi-factorial etiology. It is one of the most frequent cutaneous diseases, affecting more than eighty percent of the population at some point in their lives . Endocrine factors especially androgens and steroids are one of multiple factors provoked to be involved in pathogenesis of acne . Thyroid hormones have steroid like action that have many regulatory functions in many body organ functions including skin and pilosebaceous unit. Furthermore, subtle thyroid dysfunction was shown to have a role in many disease conditions. Thyroid hormone action on sebaceous glands is unclear. In hypothyroid states, sebocytes exhibit reduced rates of secretion that increases with thyroxine administration .

NCT ID: NCT01682785 Not yet recruiting - Clinical trials for Major Depressive Disorder

Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder

Start date: September 2012
Phase: N/A
Study type: Observational

Aim 1 is to study prevalence and 1 year incidence of metabolic syndrome in major depressive disorder and factors correlation. Aim 2 is to study prevalence and 1 year incidence of thyroid dysfunction in major depressive disorder and factors correlation.